On Monday, May 20, 2024, the FDA announced the release of “Information for Human Cell, Tissue, and Cellular and Tissue-Based Product (HCT/P) Establishments Regarding FDA’s Determination that Zika Virus is no Longer a Relevant Communicable Disease Agent or Disease” (RCDAD).

We are excited to introduce AATB’s new Publication-Based Continuing Education (CE) program, designed for tissue banking professionals.

The AATB biennial election for 2024-2026 Council Officers opens June 3. Get to know the candidates running for leadership positions on the eight AATB councils.

We are thrilled to announce the inaugural recipient of the revitalized AATB Grant Program: Dr.

We are thrilled to announce the release of the updated Certified Tissue Bank Specialist (CTBS) Recertification Guide, effective for those recertifying in 2025 and beyond.

AATB is seeking nominations for the eight AATB councils in the following leadership positions: Chairperson, Vice-Chairperson, and Secretary.

We're excited to announce that registration is now open for the BCA's 2024 Supply Chain Networkin

The AATB Annual Meeting in Aurora, CO, will provide an opportunity for members to showcase their

This testimony addresses critical legislative proposals to support patients with rare diseases, including H.R. 6705, the Effective Screening and Testing for Tuberculosis Act, and H.R. 7188, the Shandra Eisenga Human Cell and Tissue Product Safety Act.